(VIANEWS) – Mobile TeleSystems OJSC (MBT), Sensus Healthcare (SRTS), The Blackstone Group (BX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Mobile TeleSystems OJSC (MBT)

7963.7% sales growth and 150.66% return on equity

Mobile TeleSystems Public Joint Stock Company offers telecommunication services in Russia.

Mobile TeleSystems OJSC’s sales growth this year is anticipated to be 7831.2% and 7% for next year.

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 544.91B for the twelve trailing months.

Volume

Today’s last reported volume for Mobile TeleSystems OJSC is 1 which is 99.45% below its average volume of 185.

Mobile TeleSystems OJSC’s sales growth for the next quarter is 7963.7%. The company’s growth estimates for the current quarter and the next is 9500% and 8504%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 150.66%.

Mobile TeleSystems OJSC’s Stock Yearly Top and Bottom Value

Mobile TeleSystems OJSC’s stock is valued at $5.50 at 11:22 EST, way under its 52-week high of $10.07 and higher than its 52-week low of $5.34.

Mobile TeleSystems OJSC’s Moving Average

Mobile TeleSystems OJSC’s worth is under its 50-day moving average of $5.50 and way under its 200-day moving average of $7.31.

2. Sensus Healthcare (SRTS)

69.1% sales growth and 17.34% return on equity

Sensus Healthcare, Inc., is a company that manufactures and markets radiation therapy equipment to medical professionals around the world.

Sensus Healthcare’s sales growth this year is expected to be 54.3% and 18.1% for next year.

Year-on-year quarterly revenue growth grew by 155.7%, now sitting on 27.04M for the twelve trailing months.

Volume

Today’s last reported volume for Sensus Healthcare is 78177 which is 63.8% below its average volume of 215960.

Sensus Healthcare’s sales growth for the next quarter is 69.1%. The company’s growth estimates for the present quarter and the next is 700% and 1000%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.34%.

Volatility

Sensus Healthcare’s last day, last week, and last month’s current intraday variation average was 0.52%, 2.13%, and 2.62%, respectively.

Sensus Healthcare’s highest amplitude of average volatility was 3.42% (day), 4.69% (last week), and 4.94% (last month), respectively.

Sensus Healthcare’s Stock Yearly Top and Bottom Value

Sensus Healthcare’s stock is valued at $7.64 at 11:22 EST, way under its 52-week high of $11.96 and way higher than its 52-week low of $3.21.

Sensus Healthcare’s Moving Average

Sensus Healthcare’s worth is under its 50-day moving average of $8.11 and above its 200-day moving average of $7.42.

3. The Blackstone Group (BX)

52.2% sales growth and 58.88% return on equity

Alternative asset management company The Blackstone Group Inc. specializes in real estate, private Equity, hedge funds solutions, credit and secondary funds of funds.

The Blackstone Group’s sales growth this year is expected to be 16.7% and 10.3% for next year.

Year-on-year quarterly revenue growth declined by 4%, now sitting on 21.97B for the twelve trailing months.

Volume

Today’s last reported volume for The Blackstone Group is 766149 which is 84.73% below its average volume of 5018970.

The Blackstone Group’s sales growth for the next quarter is 52.2%. The company’s growth estimates for the ongoing quarter and the next is 79.3% and 7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.88%.

Volatility

The Blackstone Group’s last day, last week, and last month’s current intraday variation average was 0.06%, 1.23%, and 2.68%, respectively.

The Blackstone Group’s highest amplitude of average volatility was 4.66% (day), 4.48% (last week), and 4.43% (last month), respectively.

The Blackstone Group’s Stock Yearly Top and Bottom Value

The Blackstone Group’s stock is valued at $97.35 at 11:22 EST, way under its 52-week high of $149.78 and way higher than its 52-week low of $86.97.

The Blackstone Group’s Moving Average

The Blackstone Group’s value is under its 50-day moving average of $105.04 and way below its 200-day moving average of $121.29.

4. South State Corporation (SSB)

21.3% sales growth and 8.67% return on equity

South State Corporation is the bank holding company of South State Bank. It offers a variety of products and services.

South State Corporation’s sales growth this year is expected to be 12.2% and 10.4% for next year.

Year-on-year quarterly revenue growth declined by 14.6%, now sitting on 1.49B for the twelve trailing months.

Volume

Today’s last reported volume for South State Corporation is 335014 which is 9.93% below its average volume of 371974.

South State Corporation’s sales growth for the next quarter is 21.3%. The company’s growth estimates for the current quarter and the next is a negative 17.6% and negative -12.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.67%.

Volatility

South State Corporation’s last day, last week, and last month’s current intraday variation average was 0.99%, 1.76%, and 1.67%, respectively.

South State Corporation’s highest amplitude of average volatility was 2.85% (day), 3.42% (last week), and 2.72% (last month), respectively.

South State Corporation’s Stock Yearly Top and Bottom Value

South State Corporation’s stock is valued at $78.72 at 11:22 EST, way under its 52-week high of $93.34 and way higher than its 52-week low of $62.60.

South State Corporation’s Moving Average

South State Corporation’s worth is higher than its 50-day moving average of $77.86 and under its 200-day moving average of $80.28.

5. Crescent Capital BDC (CCAP)

19.9% sales growth and 13.8% return on equity

Crescent Capital BDC, Inc., is a business development firm.

Crescent Capital BDC’s sales growth this year is expected to be 15.8% and 11.7% for next year.

Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 93.47M for the twelve trailing months.

Volume

Today’s last reported volume for Crescent Capital BDC is 61434 which is 45.5% below its average volume of 112738.

Crescent Capital BDC’s sales growth for the next quarter is 19.9%. The company’s growth estimates for the present quarter and the next is a negative 42.1% and negative -64.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.8%.

Volatility

Crescent Capital BDC’s last day, last week, and last month’s current intraday variation average was 4.45%, 1.92%, and 1.51%, respectively.

Crescent Capital BDC’s highest amplitude of average volatility was 2.37% (day), 2.85% (last week), and 2.53% (last month), respectively.

Crescent Capital BDC’s Stock Yearly Top and Bottom Value

Crescent Capital BDC’s stock is valued at $15.28 at 11:23 EST, way under its 52-week high of $21.48 and higher than its 52-week low of $15.17.

Crescent Capital BDC’s Moving Average

Crescent Capital BDC’s value is way below its 50-day moving average of $17.02 and way below its 200-day moving average of $18.16.

LEAVE A REPLY

Please enter your comment!
Please enter your name here